<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article         dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>mersin univ saglık bilim derg</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Mersin Üniversitesi Sağlık Bilimleri Dergisi</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">1308-0830</issn>
                                                                                            <publisher>
                    <publisher-name>Mersin University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id/>
                                                                                                                                                                                            <title-group>
                                                                                                                        <trans-title-group xml:lang="en">
                                    <trans-title>ARAŞTIRMA MAKALESİ  Koroner Arter Hastalarında IL-6, IL-2R VE IGFBP-3 Düzeylerinin Araştırılması</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>ARAŞTIRMA MAKALESİ  Koroner Arter Hastalarında IL-6, IL-2R VE IGFBP-3 Düzeylerinin Araştırılması</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Yaroğlu</surname>
                                    <given-names>Hatice YILDIRIM</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Muşlu</surname>
                                    <given-names>Necati</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Ünal</surname>
                                    <given-names>Nil</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Ayaz</surname>
                                    <given-names>Lokman</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Yılmaz</surname>
                                    <given-names>Dilek</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Polat</surname>
                                    <given-names>Gürbüz</given-names>
                                </name>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Gümüş</surname>
                                    <given-names>Lülüfer TAMER</given-names>
                                </name>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20090901">
                    <day>09</day>
                    <month>01</month>
                    <year>2009</year>
                </pub-date>
                                        <volume>2</volume>
                                        <issue>3</issue>
                                        <fpage>28</fpage>
                                        <lpage>31</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20140613">
                        <day>06</day>
                        <month>13</month>
                        <year>2014</year>
                    </date>
                                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2008, Mersin Üniversitesi Sağlık Bilimleri Dergisi</copyright-statement>
                    <copyright-year>2008</copyright-year>
                    <copyright-holder>Mersin Üniversitesi Sağlık Bilimleri Dergisi</copyright-holder>
                </permissions>
            
                                                                                                <trans-abstract xml:lang="en">
                            <p>AbstractThe Investigation of IL-6, IL-2R and IGFBP-3 Levels in Coronary Artery Patients    Objective: Today, atherosclerosis has significance in pathogenesis of coronary artery diseases that are the main cause of mortality and morbidity. The first step in the onset of atherosclerosis is endothelial dysfunction. Investigations on the underlying mechanisms of atherosclerotic plaque formation revealed that disease development period has complex mechanisms with distinct anti-inflammatory response beyond cholesterol and lipid accumulation in arterial walls. Various inflammation cells and growth factors were found in atherosclerotic plaques. Thus, it was aimed in this study to investigate whether a relationship exists among the levels of IL-6, IL 2R, IGFBP-3 and coronary artery disease.   Method: Seventy patients with coronary artery disease (average age: 57.3&amp;amp;plusmn;13 years) and sixty control (average age: 60.9&amp;amp;plusmn;12 years) were included in our study. Fasting blood glucose and lipid profile were determined by enzymatic colorimetric method in Cobas 501 autoanalyzer. IL-6, IL-2R, IGFBP-3 levels were measured using electrochemiluminescence method with Immulite.   Results: No relationship was found among IGFBP-3, IL-6 levels and coronary artery disease. IL-2R levels were determined increasing in the coronary artery disease group in comparison to control group (653.6&amp;amp;plusmn;322.4 U/ml vs. 559.15&amp;amp;plusmn;297.3 U/ml, p=0.04).  Conclusion: It is considered that IL-2R levels can be used as a marker for the diagnosis  and prognosis of coronary artery disease.</p></trans-abstract>
                                                                                                                                    <abstract><p>Türkçe Özet:Amaç: Günümüzde önemli bir mortalite ve morbidite sebebi olan koroner arter hastalığının patogenezinde ateroskleroz önemli bir yere sahip olup, aterosklerozun başlamasında bugün kabul edilen ilk basamak endotel disfonksiyonudur. Aterosklerotik plak oluşumunun altında yatan mekanizmaların araştırılması, hastalık oluşum sürecinin, kolesterol ve lipidlerin arteryel duvarlarda birikmesinden öte, belirgin bir enflamatuvar yanıtın yer aldığı kompleks mekanizmalar içerdiğini ortaya koymuştur ve aterosklerotik plaklarda çeşitli inflamasyon hücrelerine ve büyüme faktörlerine rastlanmıştır. Bu nedenlerle bu çalışmada IL-6, IL-2R ve IGFBP-3 düzeylerinin koroner arter hastalığı ile ilişkisinin olup olmadığını araştırmayı amaçlandı.  Yöntem: Çalışma grubunu 70 koroner arter hastası (yaş ortalaması 57.3&amp;amp;plusmn;13) ve 60 kontrol (yaş ortalaması 60.9&amp;amp;plusmn;12) oluşturmaktadır. Açlık kan şekeri ve lipid profili enzimatik kolorimetrik yöntemle Cobas 501 otoanalizor cihazında; IL-6, IL-2R, IGFBP-3 düzeyleri elektrokemiluminesans yöntemi ile Immulite cihazı ile çalışıldı.   Bulgular: IGFBP-3, IL-6 düzeyleri ve koroner arter hastalığı arasında bir ilişki bulunamadı. IL-2R düzeyi koroner arter hastalarında kontrol grubu ile karşılaştırıldığında artmış olduğu bulundu (hasta; 653.6&amp;amp;plusmn;322.4 U/ml ve kontrol; 559.15&amp;amp;plusmn;297.3 U/ml, p=0.04).   Sonuç: IL-2R düzeylerinin koroner arter hastalığı tanı ve prognozunda bir belirteç olarak kullanılabileceği düşünülmektedir.</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>koroner arter hastalığı</kwd>
                                                    <kwd>   IL-6</kwd>
                                                    <kwd>   IL-2R</kwd>
                                                    <kwd>   IGFBP-3</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="en">
                                                    <kwd>CAD</kwd>
                                                    <kwd>   IL-6</kwd>
                                                    <kwd>   IL-2R</kwd>
                                                    <kwd>   IGFBP-3</kwd>
                                            </kwd-group>
                                                                                                                                        </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">Vaina S, Stefanadis C. Detection of the vulnarable coronary atheromatous plaque. Where are we now? Int J Cardiovasc Intervent 2005 ;7:75—87. to Williams KJ, Tabas I. The response to retention hypothesis of atherogenesis reinforced, Carr Opin Lipidol l998;9:47l -4.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol l997;80:1 1—6.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">Davies MJ . Pathology of arterial thrombosis. Br Med J Bull 1994;50:789-802.</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Ross R. Atherosclerosis is an inşammatory disease. Am Heart]1999;138(52):l9-20.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Woods A, Brull DJ, Humphries SE, Montgomery HE. Genetics of inşammation amd risk of coronary artery</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">6. Porsch—Oezcueruemez M, Kuntz D, Kloer HU, Luley C.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Evaluation of serum levels of solubilized adhesion molecules and cytokine reseptors in coronary heart disease. JAm Coll Cardiol 1999; 34:1995—2001.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">LE. Eleveted plasma levels of interlokin—Z and soluhle</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">lL—2 receptor in ischemic heart disease. Clin Cardiol 2001; 24:253-6.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
